Crsp stock forecast 2025.

In this recovering market, growth stocks that are still undervalued are a good option for risk-averse investors. CRISPR Therapeutics ( CRSP -1.33% ) is a gene-editing biotech company.

Crsp stock forecast 2025. Things To Know About Crsp stock forecast 2025.

CPRX Stock 12 Months Forecast. $23.30. (81.32% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Catalyst Pharma in the last 3 months. The average price target is $23.30 with a high forecast of $27.00 and a low forecast of $15.50. The average price target represents a 81.32% change from the last price of $12.85.If we look at the company’s services, clients and according to stock market experts, 1st tdoc stock forecast 2025 can go up to 170.89 USD and 2nd tdoc stock price target is 192.75 USD in 2025, Teladoc Inc. has divided its services into 6 parts which include guidance and support, expert medical services, mental health services, platform and ...CRISPR Therapeutics Stock Forecast 30 Nov. Presumably, on 11/30/2023, the price of shares will be in the range of $51.94 - $53.92. A $1.98 range width can provide 3.81% volatility. The weighted average price of this range is at $53.49, which is $0.93 higher than the previous day's weighted average price.Analysts expect revenue growth at 8% this year and further acceleration above double digits through 2025. EPS growth is also at ~25 for 2024 and 2025, respectively — very attractive at these levels.

According to our current TSLA stock forecast, the value of Tesla shares will drop by -7.59% and reach $ 220.53 per share by December 6, 2023. According to our technical indicators, the current sentiment is Neutral while the Fear & Greed Index is showing 39 (Fear).TSLA stock recorded 15/30 (50%) green days with 5.95% price volatility over the last 30 days.Rambus Inc. () Stock Market info Recommendations: Buy or sell Rambus stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Rambus share forecasts, stock quote and buy / sell signals below.According to present data Rambus's RMBS shares and potentially its market environment have been in a bullish cycle in the …

RVLV Stock 12 Months Forecast. $14.73. (0.48% Upside) Based on 14 Wall Street analysts offering 12 month price targets for Revolve Group in the last 3 months. The average price target is $14.73 with a high forecast of $18.00 and a low forecast of $10.50. The average price target represents a 0.48% change from the last price of $14.66.

CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. CRSP.US updated stock price target summary ... FY 2025. CRSP will ...The average TDOC stock price target stood at $124.77 a share, resulting in a potential 64% upside based on the last closing price of $75.86 (as of 28 February). The highest 12-month Teladoc share price forecast was $215, while the lowest was set at $67. Right after the company announced its results for the fourth quarter of the 2021 fiscal …Rambus Inc. () Stock Market info Recommendations: Buy or sell Rambus stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Rambus share forecasts, stock quote and buy / sell signals below.According to present data Rambus's RMBS shares and potentially its market environment have been in a bullish cycle in the …View the latest CRISPR Therapeutics AG (CRSP) stock price, news, historical charts, analyst ratings and financial information from WSJ.The global CRISPR gene editing market was valued at $846.2 million in 2019 and is expected to reach $10,825.1 million by 2030, registering a CAGR of 26.86% during the forecast.

That’s a rise of more than 350% from Friday’s close — and more than double Ark’s own $1,400 price target it set last year. In fact, even in the worst-case “bear” scenario, Ark thinks ...

According to 2 stock analysts, the average 12-month stock price forecast for DNA stock stock is $1.88, which predicts an increase of 45.74%. The lowest target is $1.25 and the highest is $2.50. On average, analysts rate DNA stock stock as a sell.

Shares of CRISPR Therapeutics ( CRSP -0.74%) sank 50.5% in 2021, according to data from S&P Global Market Intelligence. After surging roughly 151% across 2020's trading, investors reassessed the ...Next reporting date. February 13, 2024. EPS forecast (this quarter) -$0.20. Annual revenue (last year) $185.3M. Annual profit (last year) -$200.2M. Net profit margin.The average Romeo Power stock forecast 2025 represents a 26.03% increase from the last price of $0.740000009536743. For Romeo Power stock forecast for 2027 (5 year), 12 predictions are offered for each month of 2027 with average Romeo Power stock forecast of $0.94, a high forecast of $0.94, and a low forecast of $0.94. ...Shares of CRISPR Therapeutics ( CRSP -0.74%) sank 50.5% in 2021, according to data from S&P Global Market Intelligence. After surging roughly 151% across 2020's trading, investors reassessed the ...CRSP stock extended its rally from levels of around $107 in mid-November 2020 to $161 currently. Also, the stock has rallied a stellar 5x from levels of $34 in late March 2020 – when markets ...Oct 15, 2020 · Roku Inc - Class A (ROKU) stock price prediction is 205.24788816489 USD. The Roku Inc - Class A stock forecast is 205.24788816489 USD for 2024 November 30, Saturday; and 1033.706 USD for 2028 November 30, Thursday with technical analysis.

View the latest CRISPR Therapeutics AG (CRSP) stock price, news, historical charts, analyst ratings and financial information from WSJ.Discover historical prices for CRSP stock on Yahoo Finance. View daily, weekly or monthly format back to when CRISPR Therapeutics AG stock was issued.It's being developed as a one-time curative treatment for two blood disorders, sickle cell disease and beta thalassemia. Regulators in the U.S., the U.K., and Europe are reviewing the candidate as ...That's an eye catching number but take a step back and think about it. We hit $5.00 last week. If it doubles in 2021 that's $10.00 and if it doubles again in 2 years by 2023 that's $20.00 leaving 2024 for 30% growth to 26.00. In a growing EV market, with a fully differentiated product.Target values for the price of one Luminar Technologies share for Mar 2025. The weighted average target price per Luminar Technologies share in Mar 2025 is: 2.61. In Mar, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 15.345% volatility is expected. Pessimistic target level: 2.42.TRANSAMERICA LIFEGOALSM 2025 FUND- Performance charts including intraday, historical charts and prices and keydata. Indices Commodities Currencies StocksAccording to 42 stock analysts, the average 12-month stock price forecast for Amazon stock is $170.76, which predicts an increase of 16.14%. The lowest target is $116 and the highest is $230. On average, analysts rate Amazon stock as a strong buy.

The weighted average target price per CRISPR Therapeutics share in Dec 2023 is: 68.02. In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 15.330% volatility is expected. CRISPR Therapeutics stock price predictions for 2023 using artificial intelligence.

Competitors. The 26 analysts offering 12-month price forecasts for Halliburton Co have a median target of 49.50, with a high estimate of 56.00 and a low estimate of 44.00. The median estimate ...Meta Platforms Inc. () Stock Market info Recommendations: Buy or sell Meta Platforms stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Meta Platforms share forecasts, stock quote and buy / sell signals below.According to present data Meta Platforms's META shares and potentially its market environment have …Nov 14, 2023 · Target values for the price of one CRISPR Therapeutics share for Feb 2026. The weighted average target price per CRISPR Therapeutics share in Feb 2026 is: 39.08. In Feb, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 15.704% volatility is expected. Pessimistic target level: 35.58. CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.After this upgrade, CRISPR Therapeutics' 28 analysts are now forecasting revenues of US$239m in 2023. This would be a sizeable 40% improvement in sales compared to the last 12 months. Losses are ...Gene-editing therapies aren't common today, but years from now that could change. One company that hopes to be at the center of that transition is CRISPR Therapeutics ( CRSP -6.39%). The company...Casper Sleep Inc. (NYSE:CSPR) announced its quarterly earnings results on Monday, November, 15th. The company reported ($0.61) earnings per share for the quarter, missing the consensus estimate of ($0.43) by $0.18. The company had revenue of $156.50 million for the quarter, compared to analyst estimates of $156.15 million.According to 17 analysts, the average rating for CRSP stock is "Buy." The 12-month stock price forecast is $69.88, which is an increase of 4.72% from the latest price.CRISPR Therapeutics (CRSP) stock forecast for 2025 Last update: November 21, 2023 (07:48) Sector: Healthcare The share price of CRISPR Therapeutics AG (CRSP) now CRISPR Therapeutics AG 69.97 D 0.74% (0.52) What analysts predict: $87.78 52-week High/Low: $76.19 / $37.55 50/200 Day Moving Average: $46.64 / $51.55Apr 14, 2022 · The first chart below shows the global market size of CRISPR gene editing in 2019 and a forecast for 2030. The market is set to increase by a mind-boggling 1,179% to reach more than $10 billion by ...

The current CRISPR Therapeutics AG [ CRSP] share price is $66.73. The Score for CRSP is 52, which is 4% above its historic median score of 50, and infers lower risk than normal. CRSP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Traders Union experts conducted a comprehensive analysis and predicted that by the end of 2024 Google price will hit $179.92. Google will grow to $200.9 in 2025, $279.67 in 2028 and $348.68 in 2030. Traders Union analysts have prepared a selection of analytical forecasts from top portals for 2024, 2025, 2030.

Nov 1, 2023 · Forecast for December 2025. It is predicted that the price of one CRISPR Therapeutics share in will be in the range of $52.12 to $60.68. The width of this range will be $8.56 (14.10%). The average price is $54.03, which is $0.17 less than the average price of the previous month. Stock Price Forecast. The 5 analysts offering 12-month price forecasts for Danimer Scientific Inc have a median target of 3.00, with a high estimate of 3.75 and a low estimate of 2.00. The median ...CRISPR Therapeutics AG Stock (CRSP) is expected to reach an average price of $116.58 in 2025, with a high prediction of $154.57 and a low estimate of $78.58. This indicates an +78.88% rise from the last recorded price of $65.17.The average twelve-month price prediction for CRISPR Therapeutics is $69.88 with a high price target of $110.00 and a low price target of $42.00. Learn more on CRSP's analyst rating history. Do Wall Street analysts like CRISPR Therapeutics more than its competitors?Find real-time CRSR - Corsair Gaming Inc stock quotes, company profile, news and forecasts from CNN Business. Nov 30, 2023 · CRISPR Therapeutics will start 2025 at $49.04, then soar to $49.76 within the first six months of the year and finish 2025 at $57.16. That means +48% from today. CRISPR Therapeutics Stock Forecast 2030-2034. In this period, the CRISPR Therapeutics price would rise from $82.55 to $103.44, which is +25%. Nokia will start 2030 at $6.41, then soar to $6.54 within the first half of the year, and finish 2030 at $6.68. It is about +88% from today. Nokia Stock Price Forecast 2023-2024. Nokia price started in 2023 at $4.64. Today, Nokia traded at $3.49, so the price decreased by -25% from the beginning of the year.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Salesforce share forecasts, stock quote and buy / sell signals below. According to present data Salesforce's CRM shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).NEW YORK, Jan. 14, 2020 /PRNewswire/ --The Global Sports Analytics Market size is expected to reach $4.3 billion by 2025, rising at a market growt... NEW YORK, Jan. 14, 2020 /PRNewswire/ -- The Global Sports Analytics Market size is expecte...

Nov 28, 2023 · Target values for the price of one CRISPR Therapeutics share for Jan 2024. The weighted average target price per CRISPR Therapeutics share in Jan 2024 is: 63.59. In Jan, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 15.790% volatility is expected. Pessimistic target level: 56.98. Current. -$0.94. 1 Month Ago. -$1.09. 3 Months Ago. -$0.99. CRISPR Therapeutics AG analyst estimates, including CRSP earnings per share estimates and analyst recommendations.Based on short-term price targets offered by 37 analysts, the average price target for CrowdStrike Holdings comes to $201.46. The forecasts range from a low of $162.00 to a high of $245.00. The ...Instagram:https://instagram. best day traderenergy.stockspaypal dollar5hydroponic weed grow Dec 1, 2023 · According to 42 stock analysts, the average 12-month stock price forecast for Amazon stock is $170.76, which predicts an increase of 16.14%. The lowest target is $116 and the highest is $230. On average, analysts rate Amazon stock as a strong buy. hyeg stockbest healthcare reits For TELADOC HEALTH INC stock forecast for 2023, 2 predictions are offered for each month of 2023 with average TELADOC HEALTH INC stock forecast of $19.58, a high forecast of $20.12, and a low forecast of $19.04. The average TELADOC HEALTH INC stock forecast 2023 represents a 4.7% increase from the last price of $18.7000007629395. best banks in sc Find real-time CRSP - CRISPR Therapeutics AG stock quotes, company profile, news and forecasts from CNN Business. Nasdaq Forecast 2023, 2024, 2025. Facebook stock price predictions for March 2024. The forecast for beginning of March 349. Maximum value 377, while minimum 335. Averaged Facebook stock price for month …